osa and tirzepatide SURMOUNT-OSA Trial Results Potential Role of in Treating Obesity-Related Obstructive Sleep Apnea — @atulmalhotra13 and @ljaronne presented Friday at #ADASciSessions. Read a recap in ADA Meeting News: https://t.co/Dg0qxKO7Pp Obesity and obstructive sleep apnoea:

ScRNA-seq data of the 18-month-old hair follicles were obtained from GSE227784

We believe that everyone should have access to high-quality healthcare

Omega-3 fats for inflammation Omega-3 fatty acids have anti-inflammatory properties that may help manage osteoarthritis symptoms

While final details may continue to evolve, individuals may qualify if they meet the following general requirements: Enrollment in Medicare Part D or a Medicare Advantage plan that includes prescription drug coverage A determination by their physician that a GLP-1 medication is appropriate Meeting defined health criteria, such as obesity or certain related conditions Approval of a prior authorization request submitted by their doctor It is important to understand that not all beneficiaries will qualify for the program

, Kennedy, D